Due to evolving regulations governing the pharmaceutical industry, expanded use of social media platforms to communicate key milestone data, and the shift in how content is being utilized, late stage companies have benefited from establishing Content Management Processes earlier in the drug development lifecycle. This shift has led to the wide-spread adoption of best practices as companies look to harmonize their Content Strategy with their people, process and technology. This white paper provides the reader with a clear understanding of evolving best practices and trends as to how to create a Content Strategy that lays the foundation for the Content Management Process.